SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BME'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_C_DVAC6_0 (GRAMICIDIN A) |
4r30 | LAFORIN (Homosapiens) | 3 / 3 | ALA A 275VAL A 249TRP A 280 | BME A 503 ( 4.5A)NoneNone | 0.90A | 1c4dC-4r30A:undetectable1c4dD-4r30A:undetectable | 1c4dC-4r30A:7.801c4dD-4r30A:7.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_D_DVAD6_0 (GRAMICIDIN A) |
4r30 | LAFORIN (Homosapiens) | 3 / 3 | TRP A 280ALA A 275VAL A 249 | NoneBME A 503 ( 4.5A)None | 0.75A | 1c4dC-4r30A:undetectable1c4dD-4r30A:undetectable | 1c4dC-4r30A:7.801c4dD-4r30A:7.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CIL_A_ETSA263_1 (CARBONIC ANHYDRASEII) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | HIS A 66GLN A 90HIS A 92HIS A 94HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-3.6A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.34A | 1cilA-1kopA:29.8 | 1cilA-1kopA:33.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CLA_A_CLMA221_0 (TYPE IIICHLORAMPHENICOLACETYLTRANSFERASE) |
1cia | CHLORAMPHENICOLACETYLTRANSFERASE (Escherichiacoli) | 9 / 10 | THR A 94PHE A 103ALA A 105PHE A 135ASN A 146LEU A 160VAL A 162TYR A 168ILE A 172 | NoneNoneBME A 536 ( 4.3A)NoneNoneNoneNoneNoneNone | 0.26A | 1claA-1ciaA:37.2 | 1claA-1ciaA:99.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 12 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.90A | 1dx6A-3fnbA:14.6 | 1dx6A-3fnbA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ6_B_CAMB502_0 (CYTOCHROME P450-CAM) |
4r9i | SERPIN-18 (Bombyxmori) | 4 / 5 | PHE A 246TYR A 202VAL A 295VAL A 377 | NoneBME A 403 (-4.8A)BME A 403 ( 4.6A)None | 1.41A | 1dz6B-4r9iA:undetectable | 1dz6B-4r9iA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HXB_A_ROCA100_1 (HIV-1 PROTEASE) |
5z0c | NEROL DEHYDROGENASE (Persicariaminor) | 5 / 12 | GLY A 279VAL A 190GLY A 194GLY A 195ILE A 253 | NoneNoneBME A 405 ( 4.2A)BME A 405 (-3.3A)None | 0.83A | 1hxbA-5z0cA:undetectable | 1hxbA-5z0cA:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ICT_D_T44D129_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 6 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 1.04A | 1ictB-1e6bA:undetectable | 1ictB-1e6bA:20.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IEP_B_STIB202_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.08A | 1iepB-2qobA:26.3 | 1iepB-2qobA:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIA_A_ACTA294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 6 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.98A | 1kiaA-1r8yA:35.7 | 1kiaA-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIA_B_ACTB1294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 6 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.97A | 1kiaB-1r8yA:35.6 | 1kiaB-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIA_C_ACTC2294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 7 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.97A | 1kiaC-1r8yA:35.7 | 1kiaC-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIA_D_ACTD3294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 7 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.97A | 1kiaD-1r8yA:35.6 | 1kiaD-1r8yA:95.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MAA_D_DMED999_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 4 / 8 | GLY A 165TYR A 301SER A 233HIS A 377 | PGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.93A | 1maaD-3fnbA:13.9 | 1maaD-3fnbA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N13_D_AG2D7015_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) |
4ixu | ARGINASE-2,MITOCHONDRIAL (Homosapiens) | 4 / 7 | LEU A 65LEU A 54LEU A 61GLY A 62 | NoneNoneNoneBME A 404 ( 4.7A) | 0.86A | 1n13D-4ixuA:undetectable1n13E-4ixuA:undetectable | 1n13D-4ixuA:17.711n13E-4ixuA:10.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N3Z_A_ADNA126_1 (RIBONUCLEASE,SEMINAL) |
3lvy | CARBOXYMUCONOLACTONEDECARBOXYLASE FAMILY (Streptococcusmutans) | 5 / 9 | ALA A 83ASN A 164ALA A 73VAL A 82HIS A 85 | NoneNoneNoneNoneBME A 191 (-3.7A) | 1.49A | 1n3zA-3lvyA:undetectable | 1n3zA-3lvyA:17.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NBH_A_ACTA294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 6 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.94A | 1nbhA-1r8yA:35.1 | 1nbhA-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NBH_B_ACTB1294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 7 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.94A | 1nbhB-1r8yA:35.1 | 1nbhB-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NBH_C_ACTC2294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 6 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.93A | 1nbhC-1r8yA:35.0 | 1nbhC-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NBH_D_ACTD3294_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 7 | ASN A 138ARG A 175TYR A 220TYR A 242 | NoneBME A1282 (-4.3A)NoneNone | 0.94A | 1nbhD-1r8yA:35.1 | 1nbhD-1r8yA:95.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1O76_B_CAMB1420_0 (CYTOCHROME P450-CAM) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 4 / 8 | THR A 167LEU A 172VAL A 161THR A 239 | BME A 403 ( 4.9A)NoneNoneNone | 1.14A | 1o76B-3fnbA:undetectable | 1o76B-3fnbA:23.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1OQ5_A_CELA701_1 (CARBONIC ANHYDRASEII) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64GLU A 62GLN A 69HIS A 94LEU A 176THR A 177 | BME A 303 (-4.7A)NoneNone ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A) | 1.40A | 1oq5A-1kopA:29.7 | 1oq5A-1kopA:33.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1OQ5_A_CELA701_1 (CARBONIC ANHYDRASEII) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64GLU A 62HIS A 94LEU A 176THR A 177PRO A 180 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)None | 1.24A | 1oq5A-1kopA:29.7 | 1oq5A-1kopA:33.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_B_FUAB703_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
3lvy | CARBOXYMUCONOLACTONEDECARBOXYLASE FAMILY (Streptococcusmutans) | 3 / 3 | VAL A 182ALA A 83HIS A 85 | NoneNoneBME A 191 (-3.7A) | 0.68A | 1q23C-3lvyA:undetectable | 1q23C-3lvyA:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_G_FUAG708_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
3lvy | CARBOXYMUCONOLACTONEDECARBOXYLASE FAMILY (Streptococcusmutans) | 3 / 3 | VAL A 182ALA A 83HIS A 85 | NoneNoneBME A 191 (-3.7A) | 0.69A | 1q23H-3lvyA:undetectable | 1q23H-3lvyA:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_I_FUAI707_2 (CHLORAMPHENICOLACETYLTRANSFERASE) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | SER A 258TYR A 260PHE A 256PHE A 296PHE A 48 | BME A 316 ( 4.7A)NoneBME A 316 (-4.7A)NoneBME A 316 (-4.9A) | 1.11A | 1q23I-1zswA:undetectable | 1q23I-1zswA:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QHY_A_CLMA888_0 (CHLORAMPHENICOLPHOSPHOTRANSFERASE) |
3fxq | LYSR TYPE REGULATOROF TSAMBCD (Comamonastestosteroni) | 4 / 6 | PRO A 177MET A 178ALA A 181GLU A 186 | NoneBME A1003 ( 4.8A)NoneNone | 1.42A | 1qhyA-3fxqA:undetectable | 1qhyA-3fxqA:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 12 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.92A | 1qtiA-3fnbA:14.0 | 1qtiA-3fnbA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_B_URFB2011_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.96A | 1rxcB-3ogaA:undetectable | 1rxcB-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_C_URFC2081_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 7 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.79A | 1rxcC-3ogaA:undetectable | 1rxcC-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_D_URFD2021_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 7 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.94A | 1rxcD-3ogaA:undetectable | 1rxcD-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_E_URFE2031_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.95A | 1rxcE-3ogaA:undetectable | 1rxcE-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_F_URFF2001_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 7 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.92A | 1rxcF-3ogaA:undetectable | 1rxcF-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_K_URFK2061_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.93A | 1rxcK-3ogaA:undetectable | 1rxcK-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_L_URFL2071_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 7 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.96A | 1rxcL-3ogaA:undetectable | 1rxcL-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9A_B_BEZB307_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3t63 | PROTOCATECHUATE3,4-DIOXYGENASE BETACHAIN (Pseudomonasputida) | 5 / 12 | ILE M 491TYR M 408HIS M 460GLN M 477CYH M 489 | NoneBME M 1 ( 4.4A) FE M 600 ( 3.4A)BME M 1 ( 4.9A)None | 1.49A | 1s9aB-3t63M:13.3 | 1s9aB-3t63M:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9A_B_BEZB307_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3t63 | PROTOCATECHUATE3,4-DIOXYGENASE BETACHAIN (Pseudomonasputida) | 5 / 12 | TYR M 408ARG M 457HIS M 460GLN M 477CYH M 489 | BME M 1 ( 4.4A)BME M 1 (-3.9A) FE M 600 ( 3.4A)BME M 1 ( 4.9A)None | 1.38A | 1s9aB-3t63M:13.3 | 1s9aB-3t63M:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_L_TRPL81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1t8h | YLMD PROTEINSEQUENCE HOMOLOGUE (Geobacillusstearothermophilus) | 5 / 12 | GLY A 108HIS A 142HIS A 80ILE A 84GLY A 144 | NoneNoneNoneNoneBME A 302 (-3.3A) | 1.02A | 1utdL-1t8hA:undetectable1utdM-1t8hA:undetectable | 1utdL-1t8hA:13.001utdM-1t8hA:13.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_A_NCTA1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 4 / 8 | TYR A 420THR A 342CYH A 382LEU A 304 | NoneBME A1593 (-3.7A)NoneNone | 1.13A | 1uw6A-2j5cA:undetectable1uw6B-2j5cA:undetectable | 1uw6A-2j5cA:16.781uw6B-2j5cA:16.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UW6_T_NCTT1208_1 (ACETYLCHOLINE-BINDING PROTEIN) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 4 / 8 | LEU A 304TYR A 420THR A 342CYH A 382 | NoneNoneBME A1593 (-3.7A)None | 1.13A | 1uw6P-2j5cA:undetectable1uw6T-2j5cA:undetectable | 1uw6P-2j5cA:16.781uw6T-2j5cA:16.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VPT_A_SAMA400_0 (VP39) |
1vzo | RIBOSOMAL PROTEIN S6KINASE ALPHA 5 (Homosapiens) | 5 / 12 | ILE A 312GLY A 303VAL A 162ALA A 235LEU A 241 | NoneNoneNoneBME A1304 (-3.3A)None | 0.90A | 1vptA-1vzoA:undetectable | 1vptA-1vzoA:22.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VQ1_A_SAMA301_1 (N5-GLUTAMINEMETHYLTRANSFERASE,HEMK) |
4isc | METHYLTRANSFERASE (Pseudomonassyringaegroupgenomosp.3) | 3 / 3 | GLY A 50ASP A 71ASN A 53 | BME A 301 ( 4.7A)NoneNone | 0.66A | 1vq1A-4iscA:10.7 | 1vq1A-4iscA:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 12 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.86A | 1w6rA-3fnbA:14.4 | 1w6rA-3fnbA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 10 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.92A | 1w76B-3fnbA:13.8 | 1w76B-3fnbA:19.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XJB_A_ACTA1002_0 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
2ipj | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2 (Homosapiens) | 4 / 4 | TYR A 5PRO A 17HIS A 47PHE A 284 | BME A 326 (-4.0A)EDO A 330 (-4.6A)NoneEDO A 330 (-4.7A) | 0.07A | 1xjbA-2ipjA:56.9 | 1xjbA-2ipjA:98.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XVA_A_SAMA293_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 6 / 12 | HIS A 142ARG A 175GLY A 189TYR A 33TYR A 242TYR A 283 | NoneBME A1282 (-4.3A)NoneNoneNoneNone | 1.44A | 1xvaA-1r8yA:42.4 | 1xvaA-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XVA_A_SAMA293_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 9 / 12 | TYR A 33THR A 37VAL A 69SER A 139HIS A 142ARG A 175GLY A 189ILE A 202TYR A 242 | NoneNoneNoneNoneNoneBME A1282 (-4.3A)NoneNoneNone | 0.94A | 1xvaA-1r8yA:42.4 | 1xvaA-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XVA_A_SAMA293_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 10 / 12 | TYR A 33VAL A 69ASP A 70SER A 139HIS A 142ARG A 175GLY A 189ILE A 202TYR A 242TYR A 283 | NoneNoneNoneNoneNoneBME A1282 (-4.3A)NoneNoneNoneNone | 0.71A | 1xvaA-1r8yA:42.4 | 1xvaA-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XVA_B_SAMB293_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 6 / 12 | ALA A 64ASP A 70ASN A 138ARG A 175TYR A 194TYR A 283 | NoneNoneNoneBME A1282 (-4.3A)NoneNone | 1.16A | 1xvaB-1r8yA:42.1 | 1xvaB-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASEII) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 7 / 12 | ASN A 64GLN A 69HIS A 94VAL A 113LEU A 176THR A 177THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 1.36A | 1zgfA-1kopA:29.6 | 1zgfA-1kopA:33.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A7Q_A_CFBA328_2 (DEOXYCYTIDINE KINASE) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 4 / 4 | ILE A 120ASP A 93LEU A 99ARG A 325 | NoneNoneNoneBME A1592 ( 4.0A) | 1.45A | 2a7qA-2j5cA:undetectable | 2a7qA-2j5cA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
4i7l | LYSOZYME (EscherichiavirusT4) | 5 / 12 | ALA A 129PHE A 153LEU A 133ALA A 130ILE A 78 | NoneIPH A 202 (-4.4A)NoneBME A 210 ( 4.3A)IPH A 202 ( 4.5A) | 1.00A | 2aclA-4i7lA:undetectable2aclE-4i7lA:undetectable | 2aclA-4i7lA:21.052aclE-4i7lA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AW1_A_COXA264_1 (CARBONIC ANHYDRASEII) |
2cai | GLUTATHIONES-TRANSFERASE 28 KDA (Schistosomahaematobium) | 5 / 12 | ILE A 58VAL A 56VAL A 8LEU A 24THR A 23 | BME A1220 ( 4.5A)NoneNoneNoneNone | 1.01A | 2aw1A-2caiA:undetectable | 2aw1A-2caiA:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BFP_A_H4BA1290_1 (PTERIDINE REDUCTASE1) |
3ne7 | ACETYLTRANSFERASE (Thermoplasmaacidophilum) | 4 / 8 | PHE A 143LEU A 108TYR A 138LEU A 80 | NoneNoneBME A 162 ( 4.9A)BME A 163 (-4.9A) | 1.05A | 2bfpA-3ne7A:undetectable | 2bfpA-3ne7A:19.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_E_SAME301_1 (CEPHALOSPORINHYDROXYLASE CMCI) |
6cvq | APRATAXIN (Homosapiens) | 3 / 3 | SER A 174ASP A 193CYH A 272 | AMP A 401 (-2.2A)AMP A 401 (-2.2A)BME A 404 (-2.7A) | 1.03A | 2br4E-6cvqA:undetectable | 2br4E-6cvqA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYS_W_CHDW101_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 1) |
2igp | RETINOBLASTOMA-ASSOCIATED PROTEIN HEC (Homosapiens) | 4 / 6 | LEU A 185ARG A 97THR A 104LEU A 103 | NoneBME A 269 (-3.2A)NoneNone | 0.96A | 2dysN-2igpA:undetectable2dysW-2igpA:undetectable | 2dysN-2igpA:12.502dysW-2igpA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE) |
3od1 | ATPPHOSPHORIBOSYLTRANSFERASE REGULATORYSUBUNIT (Bacillushalodurans) | 4 / 7 | GLY A 223GLY A 222ALA A 225ALA A 226 | BME A 401 (-4.2A)BME A 401 ( 3.7A)BME A 401 (-3.5A)BME A 401 ( 4.4A) | 0.65A | 2ha4B-3od1A:undetectable | 2ha4B-3od1A:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HC4_A_VDXA525_1 (VITAMIN D RECEPTOR) |
5z0c | NEROL DEHYDROGENASE (Persicariaminor) | 5 / 12 | LEU A 196SER A 53CYH A 51HIS A 260LEU A 265 | BME A 405 (-3.9A) ZN A 402 ( 3.9A) ZN A 402 (-2.3A)NoneNone | 1.07A | 2hc4A-5z0cA:undetectable | 2hc4A-5z0cA:15.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HKK_A_ALEA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 4 / 6 | ASN A 64HIS A 66GLN A 90THR A 178 | BME A 303 (-4.7A)BME A 303 (-3.6A)NoneAZI A 305 ( 4.2A) | 0.36A | 2hkkA-1kopA:29.5 | 2hkkA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HYY_D_STID600_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670MET A 674ILE A 697THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 1.03A | 2hyyD-2qobA:26.4 | 2hyyD-2qobA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HYY_D_STID600_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651ILE A 673ILE A 697THR A 699LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 0.95A | 2hyyD-2qobA:26.4 | 2hyyD-2qobA:33.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KCE_A_D16A566_2 (THYMIDYLATE SYNTHASE) |
1jof | CARBOXY-CIS,CIS-MUCONATE CYCLASE (Neurosporacrassa) | 3 / 3 | HIS A 3ILE A 336LEU A 26 | BME A 368 (-3.3A)NoneNone | 0.71A | 2kceA-1jofA:undetectable | 2kceA-1jofA:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2N27_A_4DYA205_1 (CALMODULIN) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 11 | LEU A 85THR A 33ILE A 36LEU A 234VAL A 31 | NoneNoneBME A 602 (-3.9A)NoneNone | 1.47A | 2n27A-2w3pA:0.0 | 2n27A-2w3pA:14.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PL0_A_STIA200_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670MET A 674ILE A 697THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.94A | 2pl0A-2qobA:18.3 | 2pl0A-2qobA:38.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2POU_A_I7AA1000_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 7 / 12 | ASN A 64GLN A 69HIS A 94VAL A 113LEU A 176THR A 177THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 1.32A | 2pouA-1kopA:29.4 | 2pouA-1kopA:33.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q6H_A_CXXA801_1 (TRANSPORTER) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 5 / 11 | ARG A 325ILE A 92PHE A 124LEU A 272ASP A 276 | BME A1592 ( 4.0A)NoneNoneNoneNone | 0.84A | 2q6hA-2j5cA:undetectable | 2q6hA-2j5cA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QB4_A_DSMA801_1 (TRANSPORTER) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 5 / 12 | ARG A 325ILE A 92PHE A 124LEU A 272ASP A 276 | BME A1592 ( 4.0A)NoneNoneNoneNone | 0.85A | 2qb4A-2j5cA:undetectable | 2qb4A-2j5cA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEI_A_CXXA801_1 (TRANSPORTER) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 5 / 11 | ARG A 325ILE A 92PHE A 124LEU A 272ASP A 276 | BME A1592 ( 4.0A)NoneNoneNoneNone | 0.87A | 2qeiA-2j5cA:undetectable | 2qeiA-2j5cA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QJU_A_DSMA801_1 (TRANSPORTER) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 5 / 11 | ARG A 325ILE A 92PHE A 124LEU A 272ASP A 276 | BME A1592 ( 4.0A)NoneNoneNoneNone | 0.89A | 2qjuA-2j5cA:undetectable | 2qjuA-2j5cA:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R5Q_B_1UNB900_1 (PROTEASE) |
3nh9 | ATP-BINDING CASSETTESUB-FAMILY B MEMBER6, MITOCHONDRIAL (Homosapiens) | 5 / 9 | LEU A 769ILE A 684GLY A 687VAL A 772ILE A 737 | BME A 3 ( 4.9A)NoneNoneNoneNone | 1.13A | 2r5qA-3nh9A:undetectable | 2r5qA-3nh9A:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R5Q_D_1UND900_1 (PROTEASE) |
3nh9 | ATP-BINDING CASSETTESUB-FAMILY B MEMBER6, MITOCHONDRIAL (Homosapiens) | 5 / 9 | LEU A 769ILE A 684GLY A 687VAL A 772ILE A 737 | BME A 3 ( 4.9A)NoneNoneNoneNone | 1.13A | 2r5qC-3nh9A:undetectable | 2r5qC-3nh9A:16.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XFF_A_QPSA600_1 (BETA-AMYLASE) |
1btc | BETA-AMYLASE (Glycinemax) | 10 / 12 | ALA A 184GLU A 186ARG A 188TYR A 192GLN A 194TRP A 198SER A 297GLY A 298HIS A 300MET A 346 | BME A 502 ( 3.9A)NoneNoneNoneGLC A 499 ( 4.0A)NoneNoneBME A 504 ( 4.3A)GLC A 499 ( 4.0A)GLC A 499 (-3.7A) | 0.67A | 2xffA-1btcA:61.8 | 2xffA-1btcA:62.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XFF_A_QPSA600_1 (BETA-AMYLASE) |
1btc | BETA-AMYLASE (Glycinemax) | 10 / 12 | ALA A 184GLU A 186ARG A 188TYR A 192TRP A 198PHE A 200SER A 297GLY A 298HIS A 300MET A 346 | BME A 502 ( 3.9A)NoneNoneNoneNoneGLC A 499 ( 3.6A)NoneBME A 504 ( 4.3A)GLC A 499 ( 4.0A)GLC A 499 (-3.7A) | 0.50A | 2xffA-1btcA:61.8 | 2xffA-1btcA:62.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XFF_A_QPSA600_1 (BETA-AMYLASE) |
1btc | BETA-AMYLASE (Glycinemax) | 6 / 12 | TYR A 192GLN A 194TRP A 198SER A 297GLY A 298THR A 342 | NoneGLC A 499 ( 4.0A)NoneNoneBME A 504 ( 4.3A)None | 1.10A | 2xffA-1btcA:61.8 | 2xffA-1btcA:62.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XP2_A_VGHA9000_1 (TYROSINE-PROTEINKINASE RECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 9 | VAL A 635ALA A 651MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)PTR A 701 ( 3.5A)NoneNoneNone | 0.47A | 2xp2A-2qobA:34.3 | 2xp2A-2qobA:33.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XPW_A_OTCA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 12 | PHE A 256HIS A 9GLN A 39ILE A 251SER A 258 | BME A 316 (-4.7A) ZN A 315 ( 3.3A)BME A 316 ( 4.9A)NoneBME A 316 ( 4.7A) | 1.22A | 2xpwA-1zswA:0.0 | 2xpwA-1zswA:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_A_B49A1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651ILE A 683MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNone | 0.66A | 2y7jA-2qobA:25.5 | 2y7jA-2qobA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_B_B49B1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 10 | VAL A 635ALA A 651ILE A 683MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNone | 0.59A | 2y7jB-2qobA:20.0 | 2y7jB-2qobA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_C_B49C1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 10 | VAL A 635ALA A 651ILE A 683MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNone | 0.64A | 2y7jC-2qobA:25.5 | 2y7jC-2qobA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_D_B49D1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 10 | VAL A 635ALA A 651ILE A 683MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNone | 0.57A | 2y7jD-2qobA:25.9 | 2y7jD-2qobA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZLC_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
5z0c | NEROL DEHYDROGENASE (Persicariaminor) | 5 / 12 | LEU A 196SER A 53CYH A 51HIS A 260LEU A 265 | BME A 405 (-3.9A) ZN A 402 ( 3.9A) ZN A 402 (-2.3A)NoneNone | 1.14A | 2zlcA-5z0cA:undetectable | 2zlcA-5z0cA:15.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_J_CHDJ60_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 1) |
2igp | RETINOBLASTOMA-ASSOCIATED PROTEIN HEC (Homosapiens) | 4 / 6 | LEU A 185ARG A 97THR A 104LEU A 103 | NoneBME A 269 (-3.2A)NoneNone | 0.99A | 2zxwA-2igpA:undetectable2zxwJ-2igpA:undetectable | 2zxwA-2igpA:12.502zxwJ-2igpA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZZN_B_SAMB402_0 (UNCHARACTERIZEDPROTEIN MJ0883) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 12 | PHE A 90LEU A 171GLY A 93ILE A 36ASP A 37 | NoneNoneNoneBME A 602 (-3.9A)None | 1.31A | 2zznB-2w3pA:undetectable | 2zznB-2w3pA:21.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AVP_A_MV2A313_1 (PANTOTHENATE KINASE) |
1btc | BETA-AMYLASE (Glycinemax) | 4 / 7 | VAL A 363ASP A 348ILE A 394ASN A 397 | BME A 504 (-4.5A)NoneNoneNone | 0.97A | 3avpA-1btcA:0.0 | 3avpA-1btcA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AXT_A_SAMA397_0 (PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1) |
5z0c | NEROL DEHYDROGENASE (Persicariaminor) | 5 / 12 | LEU A 196ILE A 252ILE A 170SER A 174ALA A 168 | BME A 405 (-3.9A)NoneNoneNoneNone | 1.20A | 3axtA-5z0cA:6.2 | 3axtA-5z0cA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BBT_B_FMMB91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651LEU A 685THR A 699GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 0.69A | 3bbtB-2qobA:25.1 | 3bbtB-2qobA:35.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BGD_A_PM6A302_1 (THIOPURINES-METHYLTRANSFERASE) |
1pc6 | PROTEIN NINB (EscherichiavirusLambda) | 4 / 6 | THR A 77PHE A 76LEU A 49LEU A 53 | BME A 300 (-3.4A)NoneNoneNone | 0.88A | 3bgdA-1pc6A:0.0 | 3bgdA-1pc6A:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BGD_B_PM6B302_1 (THIOPURINES-METHYLTRANSFERASE) |
1pc6 | PROTEIN NINB (EscherichiavirusLambda) | 4 / 7 | THR A 77PHE A 76LEU A 49LEU A 53 | BME A 300 (-3.4A)NoneNoneNone | 0.85A | 3bgdB-1pc6A:undetectable | 3bgdB-1pc6A:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_H_SVRH504_3 (PHOSPHOLIPASE A2) |
4ich | TRANSCRIPTIONALREGULATOR (Saccharomonosporaviridis) | 5 / 11 | VAL A 258LEU A 259GLY A 255ILE A 251THR A 183 | BME A 301 (-4.6A)NoneNoneB3P A 302 ( 4.9A)None | 1.31A | 3bjwH-4ichA:undetectable | 3bjwH-4ichA:16.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BL1_A_BL1A300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 10 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94HIS A 111VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.41A | 3bl1A-1kopA:29.4 | 3bl1A-1kopA:33.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CFQ_A_DIFA1_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 6 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 0.95A | 3cfqA-1e6bA:undetectable | 3cfqA-1e6bA:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CFQ_B_DIFB1_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 7 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 0.99A | 3cfqA-1e6bA:undetectable3cfqB-1e6bA:undetectable | 3cfqA-1e6bA:19.073cfqB-1e6bA:19.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLA_A_CLMA221_0 (TYPE IIICHLORAMPHENICOLACETYLTRANSFERASE) |
1cia | CHLORAMPHENICOLACETYLTRANSFERASE (Escherichiacoli) | 8 / 9 | GLN A 92ALA A 105PHE A 135ASN A 146LEU A 160VAL A 162TYR A 168ILE A 172 | NoneBME A 536 ( 4.3A)NoneNoneNoneNoneNoneNone | 0.28A | 3claA-1ciaA:37.4 | 3claA-1ciaA:99.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CR5_X_PNTX95_0 (PROTEIN S100-B) |
2jpt | PROTEIN S100-A1 (Bostaurus) | 3 / 3 | CYH A 85PHE A 88PHE A 89 | BME A 94 (-2.0A)NoneBME A 94 ( 4.9A) | 0.81A | 3cr5X-2jptA:4.8 | 3cr5X-2jptA:58.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CZH_A_D2VA602_2 (CYTOCHROME P450 2R1) |
4qmk | TYPE III SECRETIONSYSTEM EFFECTORPROTEIN EXOU (Pseudomonasfluorescens) | 3 / 3 | LEU A 117GLU A 179ILE A 176 | BME A 700 ( 4.9A)NoneNone | 0.58A | 3czhA-4qmkA:undetectable | 3czhA-4qmkA:21.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D2T_A_1FLA502_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 7 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 1.00A | 3d2tA-1e6bA:undetectable | 3d2tA-1e6bA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DCM_X_SAMX5452_0 (UNCHARACTERIZEDPROTEIN TM_1570) |
3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) | 5 / 11 | THR A 80ALA A 82GLY A 116GLY A 121LEU A 145 | BME A 251 ( 4.4A)BME A 251 (-3.8A)ACY A 250 (-4.5A)ACY A 250 (-3.5A)BME A 251 ( 3.9A) | 0.73A | 3dcmX-3onpA:14.2 | 3dcmX-3onpA:21.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64GLN A 69HIS A 94LEU A 176THR A 177THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 1.29A | 3f4xA-1kopA:29.1 | 3f4xA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64GLN A 69HIS A 94VAL A 113LEU A 176THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 ( 4.2A) | 1.39A | 3f4xA-1kopA:29.1 | 3f4xA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94VAL A 113VAL A 123LEU A 176THR A 177THR A 178PRO A 180TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)NoneNone | 0.45A | 3f4xA-1kopA:29.1 | 3f4xA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64HIS A 94LEU A 176THR A 177THR A 178PRO A 180 | BME A 303 (-4.7A) ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.95A | 3f4xA-1kopA:29.1 | 3f4xA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64HIS A 94VAL A 113LEU A 176THR A 178PRO A 180 | BME A 303 (-4.7A) ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 ( 4.2A)None | 0.93A | 3f4xA-1kopA:29.1 | 3f4xA-1kopA:33.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FBX_A_ACTA608_0 (PUTATIVEPHOSPHOLIPASE B-LIKE2) |
1qmj | BETA-GALACTOSIDE-BINDING LECTIN (Gallusgallus) | 3 / 3 | GLU A 86VAL A 19CYH A 88 | BME A 500 (-4.5A)NoneBME A 500 ( 1.9A) | 1.02A | 3fbxA-1qmjA:0.0 | 3fbxA-1qmjA:12.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FBX_A_ACTA608_0 (PUTATIVEPHOSPHOLIPASE B-LIKE2) |
5cz3 | M64R (Myxomavirus) | 3 / 3 | GLU A 94VAL A 93CYH A 42 | BME A 301 (-4.3A)NoneBME A 301 (-1.8A) | 1.06A | 3fbxA-5cz3A:undetectable | 3fbxA-5cz3A:16.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FHX_B_PXLB313_1 (PYRIDOXAL KINASE) |
3pzs | PYRIDOXAMINE KINASE (Yersiniapestis) | 7 / 8 | SER A 9VAL A 38PHE A 40HIS A 43THR A 44TYR A 82VAL A 219 | NoneNoneBME A 290 (-4.2A)NoneNoneNoneSO4 A 288 (-3.6A) | 0.59A | 3fhxB-3pzsA:40.4 | 3fhxB-3pzsA:31.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FRQ_B_ERYB195_1 (REPRESSOR PROTEINMPHR(A)) |
4lcv | DOUBLE C2-LIKEDOMAIN-CONTAININGPROTEIN BETA (Rattusnorvegicus) | 4 / 7 | LYS A 221ASN A 225ARG A 181HIS A 169 | NoneNoneBME A 302 (-4.5A)SO4 A 301 (-4.4A) | 1.19A | 3frqB-4lcvA:undetectable | 3frqB-4lcvA:19.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64HIS A 66GLN A 90HIS A 92HIS A 94VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-4.7A)BME A 303 (-3.6A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.48A | 3fw3A-1kopA:27.5 | 3fw3A-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 7 / 12 | HIS A 66GLN A 69HIS A 92HIS A 94LEU A 176THR A 177THR A 178 | BME A 303 (-3.6A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 1.00A | 3fw3A-1kopA:27.5 | 3fw3A-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | HIS A 66GLN A 69HIS A 94VAL A 113LEU A 176THR A 178 | BME A 303 (-3.6A)None ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 ( 4.2A) | 1.38A | 3fw3A-1kopA:27.5 | 3fw3A-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | HIS A 66HIS A 94LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-3.6A) ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 1.35A | 3fw3A-1kopA:27.5 | 3fw3A-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_B_ETSB303_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.37A | 3fw3B-1kopA:27.3 | 3fw3B-1kopA:33.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GCS_A_BAXA401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | VAL A 635ALA A 651GLU A 670ILE A 683THR A 699 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 0.89A | 3gcsA-2qobA:20.7 | 3gcsA-2qobA:25.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GCS_A_BAXA401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | VAL A 635ALA A 651ILE A 683THR A 699HIS A 744 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 0.99A | 3gcsA-2qobA:20.7 | 3gcsA-2qobA:25.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GP0_A_NILA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 11) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670ILE A 683THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.01A | 3gp0A-2qobA:21.9 | 3gp0A-2qobA:26.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 5 / 12 | GLY A 183VAL A 185LEU A 218CYH A 230ILE A 14 | BME A1462 ( 3.9A)NAD A2001 (-3.6A)NoneNoneNAD A2001 (-3.9A) | 1.23A | 3h52B-1gegA:undetectable | 3h52B-1gegA:18.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HEG_A_BAXA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 627VAL A 635ALA A 651LYS A 653GLU A 670ILE A 683THR A 699 | NoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 0.84A | 3hegA-2qobA:17.7 | 3hegA-2qobA:24.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | ASN A 64GLN A 69HIS A 94VAL A 113LEU A 176THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 ( 4.2A) | 1.29A | 3hkuA-1kopA:29.4 | 3hkuA-1kopA:33.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 9 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94VAL A 113VAL A 123LEU A 176THR A 178TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneNoneAZI A 305 (-4.2A)AZI A 305 ( 4.2A)None | 0.41A | 3hkuA-1kopA:29.4 | 3hkuA-1kopA:33.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
1t8h | YLMD PROTEINSEQUENCE HOMOLOGUE (Geobacillusstearothermophilus) | 5 / 11 | LEU A 264LEU A 62LEU A 117GLY A 95LEU A 46 | NoneNoneNoneNoneBME A 301 (-4.4A) | 1.27A | 3hm1B-1t8hA:undetectable | 3hm1B-1t8hA:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IA4_D_MTXD164_2 (DIHYDROFOLATEREDUCTASE) |
3nh9 | ATP-BINDING CASSETTESUB-FAMILY B MEMBER6, MITOCHONDRIAL (Homosapiens) | 3 / 3 | ARG A 634ILE A 779THR A 787 | ATP A 1 (-3.3A)NoneBME A 3 ( 4.3A) | 0.74A | 3ia4D-3nh9A:undetectable | 3ia4D-3nh9A:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_A_URFA254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 1.01A | 3kvvA-3ogaA:undetectable | 3kvvA-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_B_URFB254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.92A | 3kvvB-3ogaA:undetectable | 3kvvB-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_C_URFC254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.98A | 3kvvC-3ogaA:undetectable | 3kvvC-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_D_URFD254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.88A | 3kvvD-3ogaA:undetectable | 3kvvD-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_E_URFE254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.93A | 3kvvE-3ogaA:undetectable | 3kvvE-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KVV_F_URFF254_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.97A | 3kvvF-3ogaA:undetectable | 3kvvF-3ogaA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_C_VIBC223_1 (THIAMINEPYROPHOSPHOKINASE) |
2i4a | THIOREDOXIN (Acetobacteraceti) | 4 / 8 | LYS A 57ASP A 26LEU A 99LEU A 78 | BME A1001 (-2.9A)NoneNoneNone | 1.00A | 3lm8A-2i4aA:undetectable3lm8C-2i4aA:undetectable | 3lm8A-2i4aA:17.573lm8C-2i4aA:17.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MS9_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.03A | 3ms9A-2qobA:26.4 | 3ms9A-2qobA:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.08A | 3mssA-2qobA:26.5 | 3mssA-2qobA:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_C_STIC1_1 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.08A | 3mssC-2qobA:26.5 | 3mssC-2qobA:34.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NK7_B_SAMB770_0 (23S RRNAMETHYLTRANSFERASE) |
3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) | 5 / 12 | ASN A 17PHE A 115GLY A 116GLY A 121LEU A 145 | CL A 253 (-4.4A)NoneACY A 250 (-4.5A)ACY A 250 (-3.5A)BME A 251 ( 3.9A) | 0.91A | 3nk7B-3onpA:16.5 | 3nk7B-3onpA:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_A_1N1A1000_1 (P38A) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 627GLY A 628VAL A 635ALA A 651ILE A 683THR A 699LEU A 753 | NoneNoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 1.07A | 3ohtA-2qobA:5.7 | 3ohtA-2qobA:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_A_1N1A1000_1 (P38A) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 627GLY A 628VAL A 635ALA A 651LYS A 653ILE A 683LEU A 753 | NoneNoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 1.17A | 3ohtA-2qobA:5.7 | 3ohtA-2qobA:24.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PYY_A_STIA3_1 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 1.08A | 3pyyA-2qobA:26.7 | 3pyyA-2qobA:34.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SXR_A_1N1A1_1 (CYTOPLASMICTYROSINE-PROTEINKINASE BMX) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651MET A 674ILE A 697THR A 699GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.66A | 3sxrA-2qobA:32.1 | 3sxrA-2qobA:32.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3THR_B_C2FB1700_0 (GLYCINEN-METHYLTRANSFERASE) |
1r8y | GLYCINEN-METHYLTRANSFERASE (Musmusculus) | 4 / 4 | LYS A 190TYR A 279VAL A 280CYH A 282 | NoneNoneNoneBME A1282 (-2.0A) | 0.63A | 3thrB-1r8yA:43.0 | 3thrB-1r8yA:95.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UE4_B_DB8B601_1 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651MET A 674ILE A 697THR A 699GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.84A | 3ue4B-2qobA:27.4 | 3ue4B-2qobA:34.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UJ6_A_SAMA300_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 5 / 12 | GLY A 61CYH A 85ILE A 109ARG A 125ASP A 126 | SAM A 301 (-3.5A)BME A 302 (-1.9A)SAM A 301 (-4.1A)NoneNone | 0.83A | 3uj6A-4iv8A:35.4 | 3uj6A-4iv8A:59.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UJ6_A_SAMA300_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | TYR A 16ILE A 33GLY A 60CYH A 84ILE A 108ARG A 124ASP A 125 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-4.0A)NoneNone | 0.74A | 3uj6A-4mwzA:41.6 | 3uj6A-4mwzA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UJ7_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | TYR A 16ILE A 33GLY A 60CYH A 84ILE A 108ARG A 124ASP A 125 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-4.0A)NoneNone | 0.72A | 3uj7A-4mwzA:41.5 | 3uj7A-4mwzA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UJ7_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 5 / 12 | GLY A 61GLY A 63CYH A 85ARG A 125ASP A 126 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)BME A 302 (-1.9A)NoneNone | 0.80A | 3uj7B-4iv8A:35.5 | 3uj7B-4iv8A:59.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UJ7_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | ILE A 33GLY A 60GLY A 62CYH A 84ARG A 124ASP A 125 | SAM A 301 (-4.3A)SAM A 301 (-3.7A)SAM A 301 ( 3.8A)BME A 303 (-1.9A)NoneNone | 0.74A | 3uj7B-4mwzA:41.5 | 3uj7B-4mwzA:63.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W67_D_VIVD301_0 (ALPHA-TOCOPHEROLTRANSFER PROTEIN) |
3kys | TRANSCRIPTIONALENHANCER FACTORTEF-1 (Homosapiens) | 5 / 12 | VAL A 293SER A 295ILE A 372VAL A 376LEU A 386 | NoneNoneBME A 700 ( 4.9A)NoneNone | 1.23A | 3w67D-3kysA:undetectable | 3w67D-3kysA:20.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
2jls | SERINE PROTEASESUBUNIT NS3 (Denguevirus) | 5 / 10 | VAL A 544PHE A 533LEU A 270THR A 267THR A 266 | NoneNoneNoneBME A1621 (-3.6A)BME A1621 (-4.1A) | 1.25A | 3zncA-2jlsA:undetectable | 3zncA-2jlsA:19.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A79_B_P1BB601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) |
3nh9 | ATP-BINDING CASSETTESUB-FAMILY B MEMBER6, MITOCHONDRIAL (Homosapiens) | 5 / 12 | LEU A 621LEU A 749ILE A 590ILE A 632PHE A 637 | NoneNoneNoneNoneBME A 2 ( 4.4A) | 1.42A | 4a79B-3nh9A:undetectable | 4a79B-3nh9A:19.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 9 | VAL A 635ALA A 651MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)PTR A 701 ( 3.5A)NoneNoneNone | 0.43A | 4anqA-2qobA:34.1 | 4anqA-2qobA:32.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ANS_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 9 | VAL A 635ALA A 651MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)PTR A 701 ( 3.5A)NoneNoneNone | 0.41A | 4ansA-2qobA:34.0 | 4ansA-2qobA:32.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
5ugz | PUTATIVETHIOESTERASE (Escherichiacoli) | 3 / 3 | ARG A 40ARG A 43ILE A 154 | NoneBME A 301 ( 4.6A)None | 0.90A | 4b7qC-5ugzA:undetectable | 4b7qC-5ugzA:18.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651ILE A 673ILE A 683THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 0.77A | 4bkjA-2qobA:24.6 | 4bkjA-2qobA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 8 / 12 | VAL A 635ALA A 651GLU A 670ILE A 673MET A 674ILE A 683THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNoneNone | 1.06A | 4bkjB-2qobA:24.7 | 4bkjB-2qobA:34.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651ILE A 673MET A 674ILE A 683THR A 699LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 1.16A | 4bkjB-2qobA:24.7 | 4bkjB-2qobA:34.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C9N_A_CAMA1419_0 (CYTOCHROME P450) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 4 / 8 | LEU A 82LEU A 34GLY A 35VAL A 59 | NoneNoneNoneBME A 602 (-4.6A) | 0.78A | 4c9nA-2w3pA:undetectable | 4c9nA-2w3pA:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CKI_A_ADNA2022_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 11 | GLY A 628GLY A 630VAL A 635ALA A 651GLY A 705LEU A 753 | NoneNoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNone | 0.92A | 4ckiA-2qobA:33.6 | 4ckiA-2qobA:29.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CLA_A_CLMA221_0 (TYPE IIICHLORAMPHENICOLACETYLTRANSFERASE) |
1cia | CHLORAMPHENICOLACETYLTRANSFERASE (Escherichiacoli) | 9 / 11 | GLN A 92THR A 94ALA A 105LEU A 134PHE A 135ASN A 146VAL A 162TYR A 168ILE A 172 | NoneNoneBME A 536 ( 4.3A)NoneNoneNoneNoneNoneNone | 0.22A | 4claA-1ciaA:37.3 | 4claA-1ciaA:99.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
5wxi | EARP (Neisseriameningitidis) | 3 / 3 | ARG A 29ARG A 26TRP A 25 | NoneNoneBME A 402 (-4.2A) | 1.47A | 4cpzC-5wxiA:undetectable | 4cpzC-5wxiA:10.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
5wxi | EARP (Neisseriameningitidis) | 3 / 3 | ARG A 29ARG A 26TRP A 25 | NoneNoneBME A 402 (-4.2A) | 1.39A | 4cpzE-5wxiA:undetectable | 4cpzE-5wxiA:10.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
5wxi | EARP (Neisseriameningitidis) | 3 / 3 | ARG A 29ARG A 26TRP A 25 | NoneNoneBME A 402 (-4.2A) | 1.45A | 4cpzH-5wxiA:undetectable | 4cpzH-5wxiA:10.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CSV_A_STIA1265_1 (SRC-ABL TYROSINEKINASE ANCESTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670ILE A 673MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.94A | 4csvA-2qobA:27.5 | 4csvA-2qobA:39.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DTZ_A_LDPA501_1 (CYTOCHROME P450 BM3VARIANT 8C8) |
2ipj | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2 (Homosapiens) | 4 / 6 | ALA A 218ALA A 253PRO A 252LEU A 235 | NoneNAP A 1 (-3.5A)BME A 327 (-4.5A)None | 0.92A | 4dtzA-2ipjA:undetectable | 4dtzA-2ipjA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3VARIANT 8C8) |
1s3i | 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE (Rattusnorvegicus) | 4 / 6 | ALA A 184ALA A 188PRO A 189THR A 187 | NoneNoneBME A 312 (-4.8A)None | 1.04A | 4dtzB-1s3iA:undetectable | 4dtzB-1s3iA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3VARIANT 8C8) |
2ipj | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2 (Homosapiens) | 4 / 6 | ALA A 218ALA A 253PRO A 252LEU A 235 | NoneNAP A 1 (-3.5A)BME A 327 (-4.5A)None | 0.93A | 4dtzB-2ipjA:undetectable | 4dtzB-2ipjA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DU2_A_LDPA501_1 (CYTOCHROME P450 BM3VARIANT B7) |
2ipj | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2 (Homosapiens) | 4 / 7 | ALA A 218ALA A 253PRO A 252LEU A 235 | NoneNAP A 1 (-3.5A)BME A 327 (-4.5A)None | 0.90A | 4du2A-2ipjA:undetectable | 4du2A-2ipjA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DU2_B_LDPB501_1 (CYTOCHROME P450 BM3VARIANT B7) |
2ipj | ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2 (Homosapiens) | 4 / 7 | ALA A 218ALA A 253PRO A 252LEU A 235 | NoneNAP A 1 (-3.5A)BME A 327 (-4.5A)None | 0.92A | 4du2B-2ipjA:undetectable | 4du2B-2ipjA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DX7_A_DM2A1105_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 11 | PHE A 24THR A 167GLY A 196ASN A 297GLN A 195 | NoneBME A 403 ( 4.9A)NoneNoneNone | 1.42A | 4dx7A-3fnbA:0.0 | 4dx7A-3fnbA:17.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_A_URFA1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.88A | 4e1vA-3ogaA:undetectable | 4e1vA-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_B_URFB1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 7 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.89A | 4e1vB-3ogaA:undetectable | 4e1vB-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_C_URFC1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.88A | 4e1vC-3ogaA:undetectable | 4e1vC-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_D_URFD1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.92A | 4e1vD-3ogaA:undetectable | 4e1vD-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_E_URFE1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.90A | 4e1vE-3ogaA:undetectable | 4e1vE-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_F_URFF1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 6 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.86A | 4e1vF-3ogaA:undetectable | 4e1vF-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_H_URFH1301_1 (URIDINEPHOSPHORYLASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 4 / 8 | GLY A 37ARG A 52ILE A 6VAL A 7 | NoneNoneBME A 142 ( 4.7A)None | 0.90A | 4e1vH-3ogaA:undetectable | 4e1vH-3ogaA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EIL_E_FOLE703_0 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 11 | SER A 92PHE A 97LEU A 50VAL A 59THR A 178 | NoneNoneNoneBME A 602 (-4.6A)BME A 601 (-4.1A) | 1.44A | 4eilE-2w3pA:2.5 | 4eilE-2w3pA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 12 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.90A | 4ey6A-3fnbA:14.8 | 4ey6A-3fnbA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 5 / 12 | GLY A 164GLY A 165TYR A 301SER A 233HIS A 377 | NonePGE A 404 ( 4.1A)PGE A 404 ( 3.7A)BME A 403 ( 4.0A)BME A 403 (-4.4A) | 0.88A | 4ey6B-3fnbA:14.3 | 4ey6B-3fnbA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 12 | ILE A 36LEU A 50LEU A 147GLY A 144PHE A 90 | BME A 602 (-3.9A)NoneBME A 602 (-4.6A)NoneNone | 1.19A | 4foxA-2w3pA:undetectable | 4foxA-2w3pA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FOX_B_D16B302_1 (THYMIDYLATE SYNTHASE) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 12 | ILE A 36LEU A 50LEU A 147GLY A 144PHE A 90 | BME A 602 (-3.9A)NoneBME A 602 (-4.6A)NoneNone | 1.13A | 4foxB-2w3pA:undetectable | 4foxB-2w3pA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FWD_A_BO2A801_1 (TTC1975 PEPTIDASE) |
1qdn | PROTEIN(N-ETHYLMALEIMIDESENSITIVE FUSIONPROTEIN (NSF)) (Cricetulusgriseus) | 5 / 9 | VAL A 24VAL A 23VAL A 37GLY A 32SER A 31 | NoneBME A 400 (-4.3A)NoneNoneNone | 1.17A | 4fwdA-1qdnA:undetectable | 4fwdA-1qdnA:13.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FWD_A_BO2A801_1 (TTC1975 PEPTIDASE) |
1qdn | PROTEIN(N-ETHYLMALEIMIDESENSITIVE FUSIONPROTEIN (NSF)) (Cricetulusgriseus) | 5 / 9 | VAL A 24VAL A 23VAL A 80GLY A 32SER A 31 | NoneBME A 400 (-4.3A)NoneNoneNone | 1.24A | 4fwdA-1qdnA:undetectable | 4fwdA-1qdnA:13.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G0U_F_ASWF101_1 (DNA TOPOISOMERASE2-BETA) |
1btc | BETA-AMYLASE (Glycinemax) | 4 / 6 | GLY A 298ALA A 184GLU A 186GLN A 351 | BME A 504 ( 4.3A)BME A 502 ( 3.9A)NoneGLC A 499 ( 3.6A) | 1.09A | 4g0uA-1btcA:undetectable | 4g0uA-1btcA:21.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651THR A 699MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNone | 0.44A | 4hjoA-2qobA:30.1 | 4hjoA-2qobA:33.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I89_A_1FLA201_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 6 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 1.02A | 4i89A-1e6bA:undetectable | 4i89A-1e6bA:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJI_H_BEZH501_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN YIBF) |
5z0c | NEROL DEHYDROGENASE (Persicariaminor) | 4 / 7 | ALA A 324SER A 161VAL A 351ARG A 349 | NoneNoneNoneBME A 405 (-3.0A) | 1.13A | 4ijiH-5z0cA:undetectable | 4ijiH-5z0cA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IR0_B_FCNB202_1 (METALLOTHIOLTRANSFERASE FOSB 2) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.47A | 4ir0A-1zswA:10.94ir0B-1zswA:11.4 | 4ir0A-1zswA:20.004ir0B-1zswA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_A_SAMA302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 8 / 12 | GLY A 61GLY A 63ILE A 84CYH A 85ILE A 109ARG A 125HIS A 130LEU A 131 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.9A)None | 0.33A | 4iv0A-4iv8A:36.7 | 4iv0A-4iv8A:88.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_A_SAMA302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | TYR A 16GLY A 62CYH A 84ILE A 59HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 ( 3.8A)BME A 303 (-1.9A)NoneSAM A 301 (-3.9A)None | 1.17A | 4iv0A-4mwzA:43.0 | 4iv0A-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_A_SAMA302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 11 / 12 | TYR A 16ILE A 33GLY A 60GLY A 62ILE A 83CYH A 84ILE A 108ARG A 124SER A 126HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.2A)SAM A 301 (-3.9A)None | 0.20A | 4iv0A-4mwzA:43.0 | 4iv0A-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 9 / 12 | GLY A 61GLY A 63ILE A 84CYH A 85MET A 88ASP A 108ILE A 109ARG A 125HIS A 130 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-3.3A)SAM A 301 (-3.5A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.9A) | 0.32A | 4iv0B-4iv8A:36.7 | 4iv0B-4iv8A:88.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 5 / 12 | GLY A 63CYH A 85MET A 88ILE A 60HIS A 130 | SAM A 301 ( 3.9A)BME A 302 (-1.9A)SAM A 301 (-3.3A)NoneSAM A 301 (-3.9A) | 1.08A | 4iv0B-4iv8A:36.7 | 4iv0B-4iv8A:88.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | TYR A 16GLY A 62CYH A 84MET A 87ILE A 59HIS A 129 | SAM A 301 ( 4.3A)SAM A 301 ( 3.8A)BME A 303 (-1.9A)SAM A 301 (-3.0A)NoneSAM A 301 (-3.9A) | 0.96A | 4iv0B-4mwzA:44.1 | 4iv0B-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV0_B_SAMB302_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 12 / 12 | TYR A 16ILE A 33GLY A 60GLY A 62ILE A 83CYH A 84MET A 87ASP A 107ILE A 108ARG A 124SER A 126HIS A 129 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-3.0A)SAM A 301 (-3.5A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.2A)SAM A 301 (-3.9A) | 0.07A | 4iv0B-4mwzA:44.1 | 4iv0B-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 12 / 12 | GLY A 61GLY A 63ASP A 83ILE A 84CYH A 85MET A 88ASP A 108ILE A 109ARG A 125ALA A 127HIS A 130LEU A 131 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-2.7A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-3.3A)SAM A 301 (-3.5A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.4A)SAM A 301 (-3.9A)None | 0.02A | 4iv8A-4iv8A:44.0 | 4iv8A-4iv8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 7 / 12 | GLY A 63ASP A 83CYH A 85MET A 88ILE A 60HIS A 130LEU A 131 | SAM A 301 ( 3.9A)SAM A 301 (-2.7A)BME A 302 (-1.9A)SAM A 301 (-3.3A)NoneSAM A 301 (-3.9A)None | 1.16A | 4iv8A-4iv8A:44.0 | 4iv8A-4iv8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 11 / 12 | GLY A 60GLY A 62ASP A 82ILE A 83CYH A 84MET A 87ASP A 107ILE A 108ARG A 124HIS A 129LEU A 130 | SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-2.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-3.0A)SAM A 301 (-3.5A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.9A)None | 0.32A | 4iv8A-4mwzA:36.4 | 4iv8A-4mwzA:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | GLY A 62ASP A 82CYH A 84MET A 87ILE A 59HIS A 129LEU A 130 | SAM A 301 ( 3.8A)SAM A 301 (-2.8A)BME A 303 (-1.9A)SAM A 301 (-3.0A)NoneSAM A 301 (-3.9A)None | 1.14A | 4iv8A-4mwzA:36.4 | 4iv8A-4mwzA:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 6 / 12 | GLY A 61GLY A 63ASP A 83CYH A 85MET A 88LEU A 129 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-2.7A)BME A 302 (-1.9A)SAM A 301 (-3.3A)None | 1.47A | 4iv8B-4iv8A:42.5 | 4iv8B-4iv8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 12 / 12 | GLY A 61GLY A 63ASP A 83ILE A 84CYH A 85MET A 88ASP A 108ILE A 109ARG A 125ALA A 127HIS A 130LEU A 131 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-2.7A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-3.3A)SAM A 301 (-3.5A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.4A)SAM A 301 (-3.9A)None | 0.09A | 4iv8B-4iv8A:42.5 | 4iv8B-4iv8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 8 / 12 | GLY A 63ASP A 83CYH A 85MET A 88ILE A 60ALA A 127HIS A 130LEU A 131 | SAM A 301 ( 3.9A)SAM A 301 (-2.7A)BME A 302 (-1.9A)SAM A 301 (-3.3A)NoneSAM A 301 (-3.4A)SAM A 301 (-3.9A)None | 1.17A | 4iv8B-4iv8A:42.5 | 4iv8B-4iv8A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | GLY A 60GLY A 62ASP A 82CYH A 84MET A 87ARG A 124LEU A 138 | SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-2.8A)BME A 303 (-1.9A)SAM A 301 (-3.0A)NoneNone | 1.00A | 4iv8B-4mwzA:36.4 | 4iv8B-4mwzA:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 11 / 12 | GLY A 60GLY A 62ASP A 82ILE A 83CYH A 84MET A 87ASP A 107ILE A 108ARG A 124HIS A 129LEU A 130 | SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-2.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-3.0A)SAM A 301 (-3.5A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.9A)None | 0.35A | 4iv8B-4mwzA:36.4 | 4iv8B-4mwzA:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | GLY A 62ASP A 82CYH A 84MET A 87ILE A 59HIS A 129LEU A 130 | SAM A 301 ( 3.8A)SAM A 301 (-2.8A)BME A 303 (-1.9A)SAM A 301 (-3.0A)NoneSAM A 301 (-3.9A)None | 1.17A | 4iv8B-4mwzA:36.4 | 4iv8B-4mwzA:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IV8_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | GLY A 62ASP A 82ILE A 83CYH A 84MET A 87LEU A 109 | SAM A 301 ( 3.8A)SAM A 301 (-2.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-3.0A)None | 1.28A | 4iv8B-4mwzA:36.4 | 4iv8B-4mwzA:87.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH3_A_FCNA204_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 12 | HIS A 222ARG A 253TYR A 260GLU A 270HIS A 9 | ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) ZN A 315 ( 3.3A) | 1.48A | 4jh3A-1zswA:11.04jh3B-1zswA:7.6 | 4jh3A-1zswA:17.994jh3B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH3_B_FCNB203_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.47A | 4jh3A-1zswA:11.04jh3B-1zswA:11.1 | 4jh3A-1zswA:17.994jh3B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH4_A_FCNA202_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 222ARG A 253TYR A 260GLU A 270HIS A 9 | ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) ZN A 315 ( 3.3A) | 1.50A | 4jh4A-1zswA:7.74jh4B-1zswA:11.0 | 4jh4A-1zswA:17.994jh4B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH4_B_FCNB202_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.49A | 4jh4A-1zswA:7.74jh4B-1zswA:11.0 | 4jh4A-1zswA:17.994jh4B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH5_A_FCNA202_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 222ARG A 253TYR A 260GLU A 270HIS A 9 | ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) ZN A 315 ( 3.3A) | 1.47A | 4jh5A-1zswA:7.74jh5B-1zswA:10.9 | 4jh5A-1zswA:17.994jh5B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH5_B_FCNB203_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 11 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.48A | 4jh5A-1zswA:7.74jh5B-1zswA:10.9 | 4jh5A-1zswA:17.994jh5B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH6_A_FCNA202_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 10 | HIS A 222ARG A 253TYR A 260GLU A 270HIS A 9 | ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) ZN A 315 ( 3.3A) | 1.47A | 4jh6A-1zswA:11.14jh6B-1zswA:11.0 | 4jh6A-1zswA:17.994jh6B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH6_B_FCNB202_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 10 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.48A | 4jh6A-1zswA:11.14jh6B-1zswA:11.0 | 4jh6A-1zswA:17.994jh6B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH8_A_FCNA204_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 10 | HIS A 222ARG A 253TYR A 260GLU A 270HIS A 9 | ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) ZN A 315 ( 3.3A) | 1.48A | 4jh8A-1zswA:7.64jh8B-1zswA:10.9 | 4jh8A-1zswA:17.994jh8B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JH8_B_FCNB203_1 (METALLOTHIOLTRANSFERASE FOSB) |
1zsw | GLYOXALASE FAMILYPROTEIN (Bacilluscereus) | 5 / 10 | HIS A 9HIS A 222ARG A 253TYR A 260GLU A 270 | ZN A 315 ( 3.3A) ZN A 315 ( 3.3A)BME A 316 (-4.5A)None ZN A 315 ( 2.5A) | 1.47A | 4jh8A-1zswA:7.64jh8B-1zswA:10.9 | 4jh8A-1zswA:17.994jh8B-1zswA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KJJ_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
2au1 | IGG-DEGRADINGPROTEASE (Streptococcuspyogenes) | 4 / 4 | ASP A 90LEU A 93ARG A 259THR A 85 | NoneNoneBME A 400 (-3.6A)None | 1.43A | 4kjjA-2au1A:undetectable | 4kjjA-2au1A:17.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KJK_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
2au1 | IGG-DEGRADINGPROTEASE (Streptococcuspyogenes) | 4 / 4 | ASP A 90LEU A 93ARG A 259THR A 85 | NoneNoneBME A 400 (-3.6A)None | 1.35A | 4kjkA-2au1A:undetectable | 4kjkA-2au1A:17.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUK_A_RBFA201_2 (BLUE-LIGHTPHOTORECEPTOR) |
3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) | 5 / 9 | VAL A 36ILE A 35ARG A 34LEU A 33GLY A 19 | NoneNoneBME A 254 (-3.3A)NoneNone | 0.92A | 4kukA-3onpA:undetectable | 4kukA-3onpA:19.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2R_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94VAL A 113VAL A 123LEU A 176THR A 177THR A 178PRO A 180TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)NoneNone | 0.43A | 4m2rA-1kopA:29.8 | 4m2rA-1kopA:33.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | TRP A 7HIS A 66GLN A 90HIS A 92HIS A 94VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | NoneBME A 303 (-3.6A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.33A | 4m2uA-1kopA:29.8 | 4m2uA-1kopA:33.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 7 / 12 | TRP A 7HIS A 66HIS A 92LEU A 176THR A 177THR A 178TRP A 187 | NoneBME A 303 (-3.6A) ZN A 301 ( 3.2A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 1.41A | 4m2uA-1kopA:29.8 | 4m2uA-1kopA:33.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M83_B_ERYB501_0 (OLEANDOMYCINGLYCOSYLTRANSFERASE) |
2j5c | 1,8-CINEOLE SYNTHASE (Salviafruticosa) | 5 / 11 | HIS A 454TRP A 367ASN A 388ILE A 337ALA A 339 | NoneNoneNoneNoneBME A1593 ( 4.8A) | 1.47A | 4m83B-2j5cA:undetectable | 4m83B-2j5cA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MBS_A_MRVA1101_2 (CHIMERA PROTEIN OFC-C CHEMOKINERECEPTOR TYPE 5 ANDRUBREDOXIN) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 4 / 7 | GLN A 524THR A 178THR A 114THR A 511 | BME A 601 (-4.4A)BME A 601 (-4.1A)NoneNone | 1.07A | 4mbsA-2w3pA:undetectable | 4mbsA-2w3pA:21.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651LYS A 653GLY A 705SER A 709LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.68A | 4mkcA-2qobA:34.2 | 4mkcA-2qobA:33.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
3t63 | PROTOCATECHUATE3,4-DIOXYGENASE BETACHAIN (Pseudomonasputida) | 3 / 3 | ARG M 457TRP M 449ILE M 491 | BME M 1 (-3.9A)BME M 542 (-4.4A)None | 0.76A | 4mwxA-3t63M:undetectable | 4mwxA-3t63M:21.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 9 / 12 | GLY A 61GLY A 63ILE A 84CYH A 85MET A 88ILE A 109ARG A 125HIS A 130LEU A 131 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-3.3A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.9A)None | 0.34A | 4mwzA-4iv8A:36.4 | 4mwzA-4iv8A:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 6 / 12 | GLY A 63CYH A 85MET A 88ILE A 60HIS A 130LEU A 131 | SAM A 301 ( 3.9A)BME A 302 (-1.9A)SAM A 301 (-3.3A)NoneSAM A 301 (-3.9A)None | 1.27A | 4mwzA-4iv8A:36.4 | 4mwzA-4iv8A:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 7 / 12 | TYR A 16GLY A 62CYH A 84MET A 87ILE A 59HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 ( 3.8A)BME A 303 (-1.9A)SAM A 301 (-3.0A)NoneSAM A 301 (-3.9A)None | 1.16A | 4mwzA-4mwzA:47.3 | 4mwzA-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_A_SAMA301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 12 / 12 | TYR A 16ILE A 33GLY A 60GLY A 62ILE A 83CYH A 84MET A 87ILE A 108ARG A 124SER A 126HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-3.0A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.2A)SAM A 301 (-3.9A)None | 0.02A | 4mwzA-4mwzA:47.3 | 4mwzA-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4iv8 | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumknowlesi) | 8 / 12 | GLY A 61GLY A 63ILE A 84CYH A 85ILE A 109ARG A 125HIS A 130LEU A 131 | SAM A 301 (-3.5A)SAM A 301 ( 3.9A)SAM A 301 (-3.8A)BME A 302 (-1.9A)SAM A 301 (-4.1A)NoneSAM A 301 (-3.9A)None | 0.36A | 4mwzB-4iv8A:36.5 | 4mwzB-4iv8A:87.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 6 / 12 | TYR A 16GLY A 62CYH A 84ILE A 59HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 ( 3.8A)BME A 303 (-1.9A)NoneSAM A 301 (-3.9A)None | 1.16A | 4mwzB-4mwzA:42.9 | 4mwzB-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWZ_B_SAMB301_0 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE) |
4mwz | PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE,PUTATIVE (Plasmodiumvivax) | 11 / 12 | TYR A 16ILE A 33GLY A 60GLY A 62ILE A 83CYH A 84ILE A 108ARG A 124SER A 126HIS A 129LEU A 130 | SAM A 301 ( 4.3A)SAM A 301 (-4.3A)SAM A 301 (-3.7A)SAM A 301 ( 3.8A)SAM A 301 (-3.7A)BME A 303 (-1.9A)SAM A 301 (-4.0A)NoneSAM A 301 (-3.2A)SAM A 301 (-3.9A)None | 0.24A | 4mwzB-4mwzA:42.9 | 4mwzB-4mwzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXO_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670MET A 674ILE A 697THR A 699GLY A 705 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 0.68A | 4mxoA-2qobA:28.1 | 4mxoA-2qobA:39.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXX_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651LYS A 653THR A 699MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNonePTR A 701 ( 3.5A)NoneNone | 0.61A | 4mxxB-2qobA:26.3 | 4mxxB-2qobA:39.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OQR_A_2UOA502_1 (CYP105AS1) |
3mjf | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Yersiniapestis) | 5 / 9 | PRO A 355VAL A 387VAL A 377THR A 379VAL A 413 | NoneNoneNoneNoneBME A 507 ( 4.5A) | 1.29A | 4oqrA-3mjfA:undetectable | 4oqrA-3mjfA:23.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P3Q_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
2au1 | IGG-DEGRADINGPROTEASE (Streptococcuspyogenes) | 4 / 5 | ASP A 90LEU A 93ARG A 259THR A 85 | NoneNoneBME A 400 (-3.6A)None | 1.41A | 4p3qA-2au1A:undetectable | 4p3qA-2au1A:17.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QCK_A_ASDA404_1 (3-KETOSTEROID-9-ALPHA-MONOOXYGENASEOXYGENASE SUBUNIT) |
1e4a | L-FUCULOSE1-PHOSPHATE ALDOLASE (Escherichiacoli) | 5 / 12 | ASN P 29VAL P 30MET P 17ASN P 23GLY P 156 | SO4 P 301 (-3.8A)BME P 303 ( 4.8A)NoneBME P 303 ( 4.4A)None | 1.04A | 4qckA-1e4aP:0.0 | 4qckA-1e4aP:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651LYS A 653GLU A 670MET A 674THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 1.02A | 4r7iA-2qobA:31.7 | 4r7iA-2qobA:29.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7L_A_SHHA709_1 (LEUKOTRIENE A-4HYDROLASE) |
2p0n | HYPOTHETICAL PROTEINNMB1532 (Neisseriameningitidis) | 5 / 12 | ALA A 62HIS A 136GLU A 140HIS A 96TYR A 133 | BME A 601 (-3.3A) MN A 605 ( 3.4A) MN A 605 (-2.4A) MN A 605 (-3.4A)None | 1.46A | 4r7lA-2p0nA:undetectable | 4r7lA-2p0nA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RUJ_A_VDXA501_1 (VITAMIN D3 RECEPTORA) |
1k2f | SIAH-1A PROTEIN (Musmusculus) | 5 / 12 | ILE A 155SER A 183VAL A 144HIS A 147HIS A 152 | BME A 550 (-4.9A)NoneNone ZN A 601 (-3.0A) ZN A 601 (-3.2A) | 1.35A | 4rujA-1k2fA:undetectable | 4rujA-1k2fA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_B_032B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | VAL A 635ALA A 651LYS A 653THR A 699SER A 706 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 0.73A | 4rzvB-2qobA:25.9 | 4rzvB-2qobA:27.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U5J_B_RXTB601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 9 | VAL A 635ALA A 651MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)PTR A 701 ( 3.5A)NoneNoneNone | 0.36A | 4u5jB-2qobA:28.1 | 4u5jB-2qobA:39.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4W5O_A_IPHA904_0 (PROTEIN ARGONAUTE-2) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 7 | ILE A 184GLN A 140PRO A 182ILE A 249 | NoneBME A1462 (-3.9A)NAD A2001 ( 3.7A)None | 1.08A | 4w5oA-1gegA:3.6 | 4w5oA-1gegA:13.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA9_B_AXIB9000_1 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651THR A 699MET A 702GLY A 705ASN A 751LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNoneNone | 0.77A | 4wa9B-2qobA:32.1 | 4wa9B-2qobA:34.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WCX_C_SAMC503_0 (BIOTIN AND THIAMINSYNTHESIS ASSOCIATED) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 5 / 12 | TYR A 48GLY A 47LEU A 540LEU A 172ALA A 94 | NoneNoneNoneNoneBME A 601 ( 4.5A) | 1.25A | 4wcxC-2w3pA:undetectable | 4wcxC-2w3pA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WOZ_F_MN9F401_0 (N-ACETYLNEURAMINATELYASE) |
5dx9 | TREHALOSE-6-PHOSPHATE PHOSPHATASE (Cryptococcusneoformans) | 4 / 5 | LEU A 157ASP A 158TYR A 141LEU A 179 | BME A 403 ( 3.5A)NoneBME A 403 (-3.4A)BME A 403 ( 4.3A) | 1.27A | 4wozF-5dx9A:undetectable4wozH-5dx9A:undetectable | 4wozF-5dx9A:22.834wozH-5dx9A:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X20_B_LOCB502_1 (TUBULIN BETA CHAIN) |
1e4a | L-FUCULOSE1-PHOSPHATE ALDOLASE (Escherichiacoli) | 5 / 12 | CYH P 14LEU P 15LEU P 50VAL P 30ILE P 55 | BME P 303 (-2.0A)NoneNoneBME P 303 ( 4.8A)None | 0.99A | 4x20B-1e4aP:undetectable | 4x20B-1e4aP:16.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE3_B_CL6B502_1 (CYTOCHROME P-450) |
1hvy | THYMIDYLATE SYNTHASE (Homosapiens) | 4 / 5 | ALA A 238THR A 241VAL A 164ILE A 165 | NoneNoneBME A1514 (-4.3A)None | 0.91A | 4xe3B-1hvyA:0.0 | 4xe3B-1hvyA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Y8W_B_STRB603_1 (CYTOCHROME P45021-HYDROXYLASE) |
2ga8 | HYPOTHETICAL 39.9KDA PROTEIN (Saccharomycescerevisiae) | 5 / 12 | VAL A 30ASP A 336ILE A 337GLY A 334VAL A 306 | NoneNoneNoneNoneBME A 501 ( 4.3A) | 1.12A | 4y8wB-2ga8A:undetectable | 4y8wB-2ga8A:22.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z4E_A_IPHA904_0 (PROTEIN ARGONAUTE-2) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 7 | ILE A 184GLN A 140PRO A 182ILE A 249 | NoneBME A1462 (-3.9A)NAD A2001 ( 3.7A)None | 1.04A | 4z4eA-1gegA:undetectable | 4z4eA-1gegA:13.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z4G_A_IPHA902_0 (PROTEIN ARGONAUTE-2) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 7 | ILE A 184GLN A 140PRO A 182ILE A 249 | NoneBME A1462 (-3.9A)NAD A2001 ( 3.7A)None | 1.06A | 4z4gA-1gegA:3.4 | 4z4gA-1gegA:13.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAA_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 9 | VAL A 635ALA A 651MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)PTR A 701 ( 3.5A)NoneNoneNone | 0.49A | 5aaaA-2qobA:34.5 | 5aaaA-2qobA:33.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAB_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 10 | VAL A 635ALA A 651LYS A 653MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNoneNone | 0.88A | 5aabA-2qobA:34.2 | 5aabA-2qobA:33.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAC_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 10 | VAL A 635ALA A 651LYS A 653MET A 702GLY A 705LEU A 753ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NonePTR A 701 ( 3.5A)NoneNoneNone | 0.90A | 5aacA-2qobA:34.0 | 5aacA-2qobA:33.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_A_4TXA201_1 (TRANSTHYRETIN) |
1e6b | GLUTATHIONES-TRANSFERASE (Arabidopsisthaliana) | 4 / 6 | LEU A 147ALA A 159LEU A 150THR A 160 | NoneNoneNoneBME A 389 ( 4.9A) | 1.03A | 5bojA-1e6bA:undetectable | 5bojA-1e6bA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F1A_A_SALA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
2j89 | METHIONINE SULFOXIDEREDUCTASE A (Populustrichocarpa) | 4 / 8 | LEU A 180TYR A 179TRP A 48GLY A 204 | NoneNoneBME A 207 ( 4.2A)None | 0.76A | 5f1aA-2j89A:undetectable | 5f1aA-2j89A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F1A_B_SALB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
2j89 | METHIONINE SULFOXIDEREDUCTASE A (Populustrichocarpa) | 4 / 7 | LEU A 180TYR A 179TRP A 48GLY A 204 | NoneNoneBME A 207 ( 4.2A)None | 0.72A | 5f1aB-2j89A:undetectable | 5f1aB-2j89A:20.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H2U_B_1N1B501_1 (PROTEIN-TYROSINEKINASE 6) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | VAL A 635ALA A 651ILE A 697THR A 699GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNone | 0.60A | 5h2uB-2qobA:24.2 | 5h2uB-2qobA:33.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HES_A_032A401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | VAL A 635ALA A 651ILE A 683ILE A 697THR A 699 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 0.54A | 5hesA-2qobA:11.7 | 5hesA-2qobA:31.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HIE_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 630VAL A 635ALA A 651ILE A 697THR A 699 | NoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNone | 0.74A | 5hieA-2qobA:26.2 | 5hieA-2qobA:31.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HIE_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 630VAL A 635ALA A 651ILE A 697THR A 699 | NoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNone | 0.76A | 5hieB-2qobA:26.3 | 5hieB-2qobA:31.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HIE_D_P06D801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 5 / 12 | GLY A 630VAL A 635ALA A 651ILE A 697THR A 699 | NoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNone | 0.75A | 5hieD-2qobA:26.3 | 5hieD-2qobA:31.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ICX_E_SC2E1_1 (CETUXIMAB FAB LIGHTCHAINMEDITOPE) |
2iuw | ALKYLATED REPAIRPROTEIN ALKB HOMOLOG3 (Homosapiens) | 3 / 3 | VAL A 270GLN A 108CYH A 110 | NoneNoneBME A 802 (-1.9A) | 0.68A | 5icxA-2iuwA:undetectable5icxE-2iuwA:undetectable | 5icxA-2iuwA:21.405icxE-2iuwA:4.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JMN_B_FUAB1101_1 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) |
3kys | TRANSCRIPTIONALENHANCER FACTORTEF-1 (Homosapiens) | 4 / 5 | ILE A 372LEU A 203HIS A 226VAL A 225 | BME A 700 ( 4.9A)NoneNoneNone | 1.24A | 5jmnB-3kysA:undetectable | 5jmnB-3kysA:11.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94GLU A 98HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 4.6A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 0.44A | 5jnaA-1kopA:27.2 | 5jnaA-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_B_TORB302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.45A | 5jnaB-1kopA:27.4 | 5jnaB-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 10 / 11 | ASN A 64GLN A 90HIS A 92HIS A 94HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A) | 0.44A | 5jnaC-1kopA:26.8 | 5jnaC-1kopA:33.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_D_TORD302_1 (CARBONIC ANHYDRASE 4) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | ASN A 64GLN A 90HIS A 92HIS A 94HIS A 111VAL A 113VAL A 123LEU A 176THR A 177THR A 178TRP A 187 | BME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)NoneNoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.41A | 5jnaD-1kopA:26.9 | 5jnaD-1kopA:33.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5K7U_A_SAMA601_1 (N6-ADENOSINE-METHYLTRANSFERASE 70 KDASUBUNIT) |
2bxy | MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE (Deinococcusradiodurans) | 3 / 3 | ASP A 329ASN A 398GLN A 401 | NoneBME A1608 (-4.3A)None | 0.75A | 5k7uA-2bxyA:undetectable | 5k7uA-2bxyA:16.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KBW_B_RBFB201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3ne7 | ACETYLTRANSFERASE (Thermoplasmaacidophilum) | 5 / 12 | GLU A 112LEU A 125GLY A 142ASN A 141VAL A 145 | NoneBME A 162 ( 3.9A)NoneGOL A 165 (-3.0A)None | 1.20A | 5kbwB-3ne7A:undetectable | 5kbwB-3ne7A:25.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KVA_A_SAMA301_0 (CAFFEOYL-COAO-METHYLTRANSFERASE) |
3all | 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLICACID OXYGENASE (Mesorhizobiumjaponicum) | 5 / 12 | MET A 293THR A 272GLY A 287ALA A 308ASP A 288 | NoneBME A 381 ( 4.7A)FAD A 380 (-3.4A)NoneFAD A 380 (-3.1A) | 0.97A | 5kvaA-3allA:2.5 | 5kvaA-3allA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KVA_B_SAMB301_0 (CAFFEOYL-COAO-METHYLTRANSFERASE) |
3all | 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLICACID OXYGENASE (Mesorhizobiumjaponicum) | 5 / 12 | MET A 293THR A 272GLY A 287ALA A 308ASP A 288 | NoneBME A 381 ( 4.7A)FAD A 380 (-3.4A)NoneFAD A 380 (-3.1A) | 0.97A | 5kvaB-3allA:2.6 | 5kvaB-3allA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L0Z_A_SAMA304_0 (PROBABLE RNAMETHYLTRANSFERASE,TRMH FAMILY) |
3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) | 5 / 12 | THR A 80GLY A 116GLY A 121LEU A 145LEU A 147 | BME A 251 ( 4.4A)ACY A 250 (-4.5A)ACY A 250 (-3.5A)BME A 251 ( 3.9A)ACY A 250 ( 4.5A) | 0.70A | 5l0zA-3onpA:17.0 | 5l0zA-3onpA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L0Z_B_SAMB304_0 (PROBABLE RNAMETHYLTRANSFERASE,TRMH FAMILY) |
3onp | TRNA/RRNAMETHYLTRANSFERASE(SPOU) (Rhodobactersphaeroides) | 5 / 10 | THR A 80GLY A 116GLY A 121LEU A 145LEU A 147 | BME A 251 ( 4.4A)ACY A 250 (-4.5A)ACY A 250 (-3.5A)BME A 251 ( 3.9A)ACY A 250 ( 4.5A) | 0.77A | 5l0zB-3onpA:7.0 | 5l0zB-3onpA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LSU_B_SAMB1304_1 (HISTONE-LYSINEN-METHYLTRANSFERASENSD2) |
5nl6 | CALPONIN DOMAINFAMILY PROTEIN (Entamoebahistolytica) | 3 / 3 | ASN A 438TYR A 285CYH A 434 | NoneNoneBME A 501 (-2.3A) | 1.11A | 5lsuB-5nl6A:undetectable | 5lsuB-5nl6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ODI_G_ACTG702_0 (HETERODISULFIDEREDUCTASE, SUBUNIT A) |
2w3p | BENZOYL-COA-DIHYDRODIOL LYASE (Paraburkholderiaxenovorans) | 3 / 3 | GLY A 177THR A 521ASN A 115 | BME A 601 (-3.7A)NoneNone | 0.68A | 5odiG-2w3pA:2.1 | 5odiG-2w3pA:21.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5P9I_A_1E8A701_1 (TYROSINE-PROTEINKINASE BTK) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 6 / 12 | GLY A 630VAL A 635ALA A 651ILE A 697THR A 699PHE A 765 | NoneBME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNone | 0.86A | 5p9iA-2qobA:25.2 | 5p9iA-2qobA:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5P9I_A_1E8A701_1 (TYROSINE-PROTEINKINASE BTK) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 9 / 12 | VAL A 635ALA A 651LYS A 653ILE A 697THR A 699GLY A 705LEU A 753SER A 763PHE A 765 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNoneNoneNone | 1.06A | 5p9iA-2qobA:25.2 | 5p9iA-2qobA:32.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXQ_B_NIZB808_1 (CATALASE-PEROXIDASE) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 8 | VAL A 144GLY A 252GLN A 140LEU A 248 | NoneNoneBME A1462 (-3.9A)None | 1.08A | 5sxqB-1gegA:undetectable | 5sxqB-1gegA:17.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SYJ_A_NIZA809_1 (CATALASE-PEROXIDASE) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 8 | VAL A 144GLY A 252GLN A 140LEU A 248 | NoneNoneBME A1462 (-3.9A)None | 1.10A | 5syjA-1gegA:undetectable | 5syjA-1gegA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T7B_A_IPHA901_0 (PROTEIN ARGONAUTE-2) |
2i5p | GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE1 (Kluyveromycesmarxianus) | 4 / 6 | PHE O 230VAL O 175ALA O 229THR O 150 | NoneNoneBME O1023 ( 4.8A)None | 1.10A | 5t7bA-2i5pO:3.5 | 5t7bA-2i5pO:18.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE0_A_XINA401_2 (AP2-ASSOCIATEDPROTEIN KINASE 1) |
4da1 | PROTEIN PHOSPHATASE1K, MITOCHONDRIAL (Homosapiens) | 4 / 5 | LEU A 160VAL A 192CYH A 145CYH A 138 | NoneNoneBME A 502 (-2.0A)None | 1.28A | 5te0A-4da1A:undetectable | 5te0A-4da1A:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUD_A_ERMA2001_2 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
1z05 | TRANSCRIPTIONALREGULATOR, ROKFAMILY (Vibriocholerae) | 4 / 7 | LEU A 321VAL A 328GLN A 361GLU A 360 | NoneNoneBME A 413 ( 4.8A)BME A 413 (-3.6A) | 1.08A | 5tudA-1z05A:undetectable | 5tudA-1z05A:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TZO_A_7V7A202_1 (ENDO-1,4-BETA-XYLANASE A) |
4da1 | PROTEIN PHOSPHATASE1K, MITOCHONDRIAL (Homosapiens) | 5 / 12 | PHE A 292VAL A 343ALA A 98ALA A 323GLY A 96 | NoneNoneNoneNoneBME A 501 ( 4.5A) | 1.39A | 5tzoA-4da1A:undetectable | 5tzoA-4da1A:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA303_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
3pzs | PYRIDOXAMINE KINASE (Yersiniapestis) | 3 / 3 | GLU A 262TYR A 263ARG A 216 | BME A 289 (-3.9A)NoneNone | 0.77A | 5uunA-3pzsA:undetectable | 5uunA-3pzsA:22.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WQP_A_NCAA302_0 (PROBABLEDEHYDROGENASE) |
1geg | ACETOIN REDUCTASE (Klebsiellapneumoniae) | 4 / 8 | SER A 139GLN A 140TYR A 152MET A 189 | BME A1462 ( 2.8A)BME A1462 (-3.9A)BME A1462 ( 4.4A)NAD A2001 (-3.5A) | 1.05A | 5wqpA-1gegA:23.2 | 5wqpA-1gegA:27.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X1F_J_CHDJ101_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
2igp | RETINOBLASTOMA-ASSOCIATED PROTEIN HEC (Homosapiens) | 4 / 6 | LEU A 185ARG A 97THR A 104LEU A 103 | NoneBME A 269 (-3.2A)NoneNone | 1.09A | 5x1fA-2igpA:undetectable5x1fJ-2igpA:undetectable | 5x1fA-2igpA:12.505x1fJ-2igpA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X23_A_LSNA502_2 (CYTOCHROME P450 2C9) |
4ixu | ARGINASE-2,MITOCHONDRIAL (Homosapiens) | 3 / 3 | LEU A 58VAL A 316ASP A 317 | BME A 404 (-4.6A)NoneNone | 0.62A | 5x23A-4ixuA:undetectable | 5x23A-4ixuA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZCP_W_CHDW101_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
2igp | RETINOBLASTOMA-ASSOCIATED PROTEIN HEC (Homosapiens) | 4 / 8 | LEU A 185ARG A 97THR A 104LEU A 103 | NoneBME A 269 (-3.2A)NoneNone | 0.91A | 5zcpN-2igpA:undetectable5zcpW-2igpA:undetectable | 5zcpN-2igpA:12.505zcpW-2igpA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZSF_A_6T0A910_0 (TOLL-LIKE RECEPTOR 7) |
4mr0 | PLASMIN ANDFIBRONECTIN-BINDINGPROTEIN A (Streptococcuspneumoniae) | 4 / 7 | THR A 366LEU A 315ILE A 292THR A 291 | BME A 701 (-4.4A)BME A 701 ( 4.3A)NoneNone | 0.90A | 5zsfA-4mr0A:2.85zsfB-4mr0A:3.5 | 5zsfA-4mr0A:7.155zsfB-4mr0A:7.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_A_ECLA1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
2r2i | GUANYLYLCYCLASE-ACTIVATINGPROTEIN 1 (Gallusgallus) | 4 / 7 | PHE A 62ILE A 70LEU A 33ILE A 177 | MYR A 1 ( 4.7A)MYR A 1 ( 4.7A)BME A 301 (-4.1A)MYR A 1 ( 4.6A) | 0.84A | 6b5vA-2r2iA:undetectable6b5vC-2r2iA:undetectable | 6b5vA-2r2iA:19.276b5vC-2r2iA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_B_ECLB1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
2r2i | GUANYLYLCYCLASE-ACTIVATINGPROTEIN 1 (Gallusgallus) | 4 / 7 | PHE A 62ILE A 70LEU A 33ILE A 177 | MYR A 1 ( 4.7A)MYR A 1 ( 4.7A)BME A 301 (-4.1A)MYR A 1 ( 4.6A) | 0.84A | 6b5vA-2r2iA:undetectable6b5vB-2r2iA:undetectable | 6b5vA-2r2iA:19.276b5vB-2r2iA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_C_ECLC1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
2r2i | GUANYLYLCYCLASE-ACTIVATINGPROTEIN 1 (Gallusgallus) | 4 / 7 | PHE A 62ILE A 70LEU A 33ILE A 177 | MYR A 1 ( 4.7A)MYR A 1 ( 4.7A)BME A 301 (-4.1A)MYR A 1 ( 4.6A) | 0.84A | 6b5vC-2r2iA:undetectable6b5vD-2r2iA:undetectable | 6b5vC-2r2iA:19.276b5vD-2r2iA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5V_D_ECLD1001_1 (TRANSIENT RECEPTORPOTENTIAL CATIONCHANNEL SUBFAMILY VMEMBER 5) |
2r2i | GUANYLYLCYCLASE-ACTIVATINGPROTEIN 1 (Gallusgallus) | 4 / 7 | PHE A 62ILE A 70LEU A 33ILE A 177 | MYR A 1 ( 4.7A)MYR A 1 ( 4.7A)BME A 301 (-4.1A)MYR A 1 ( 4.6A) | 0.84A | 6b5vB-2r2iA:undetectable6b5vD-2r2iA:undetectable | 6b5vB-2r2iA:19.276b5vD-2r2iA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 10 / 12 | TRP A 7ASN A 64HIS A 66GLN A 90HIS A 92HIS A 94LEU A 176THR A 177THR A 178TRP A 187 | NoneBME A 303 (-4.7A)BME A 303 (-3.6A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)AZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 0.52A | 6bbsA-1kopA:24.4 | 6bbsA-1kopA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 6 / 12 | TRP A 7HIS A 66HIS A 92THR A 177THR A 178TRP A 187 | NoneBME A 303 (-3.6A) ZN A 301 ( 3.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)None | 1.33A | 6bbsA-1kopA:24.4 | 6bbsA-1kopA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 11 / 12 | TRP A 7ASN A 64GLN A 90HIS A 92HIS A 94VAL A 113LEU A 176THR A 177THR A 178PRO A 180TRP A 187 | NoneBME A 303 (-4.7A)None ZN A 301 ( 3.2A) ZN A 301 ( 3.3A)NoneAZI A 305 (-4.2A)AZI A 305 (-3.4A)AZI A 305 ( 4.2A)NoneNone | 0.49A | 6bc9A-1kopA:29.8 | 6bc9A-1kopA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_2 (CARBONIC ANHYDRASE 2) |
1kop | CARBONIC ANHYDRASE (Neisseriagonorrhoeae) | 4 / 5 | HIS A 66GLU A 98HIS A 111VAL A 123 | BME A 303 (-3.6A) ZN A 301 ( 4.6A) ZN A 301 ( 3.2A)None | 0.14A | 6bc9A-1kopA:29.8 | 6bc9A-1kopA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BKL_C_EU7C101_0 (MATRIX PROTEIN 2) |
3a28 | L-2.3-BUTANEDIOLDEHYDROGENASE (Corynebacteriumglutamicum) | 5 / 9 | ALA C 183SER C 141VAL C 229VAL C 187GLY C 253 | NoneBME C4462 ( 3.3A)NoneNAD C4300 (-3.7A)None | 1.27A | 6bklA-3a28C:undetectable6bklB-3a28C:undetectable6bklC-3a28C:undetectable6bklD-3a28C:undetectable | 6bklA-3a28C:7.576bklB-3a28C:7.576bklC-3a28C:7.576bklD-3a28C:7.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_B_SAMB505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
1k2f | SIAH-1A PROTEIN (Musmusculus) | 5 / 12 | GLY A 213HIS A 147CYH A 128CYH A 130GLY A 139 | None ZN A 601 (-3.0A) ZN A 601 (-2.1A)BME A 550 (-2.1A)None | 1.27A | 6bp4B-1k2fA:undetectable | 6bp4B-1k2fA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651ILE A 683THR A 699MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNonePTR A 701 ( 3.5A)NoneNone | 0.68A | 6bsdA-2qobA:23.9 | 6bsdA-2qobA:13.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DWD_B_GLYB709_0 (DEOXYNUCLEOSIDETRIPHOSPHATETRIPHOSPHOHYDROLASESAMHD1) |
1k2f | SIAH-1A PROTEIN (Musmusculus) | 4 / 5 | GLY A 229ASN A 228ARG A 232ARG A 233 | NoneNoneNoneBME A 553 ( 4.3A) | 1.35A | 6dwdB-1k2fA:0.06dwdD-1k2fA:0.0 | 6dwdB-1k2fA:14.266dwdD-1k2fA:14.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F7L_B_ACTB505_0 (AMINE OXIDASE LKCE) |
5dx9 | TREHALOSE-6-PHOSPHATE PHOSPHATASE (Cryptococcusneoformans) | 3 / 3 | HIS A 140ASN A 178LEU A 179 | T6P A 402 (-3.7A)T6P A 402 (-3.5A)BME A 403 ( 4.3A) | 0.90A | 6f7lB-5dx9A:2.6 | 6f7lB-5dx9A:19.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6FNM_A_1N1A1001_1 (-) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 10 / 12 | VAL A 635ALA A 651LYS A 653GLU A 670MET A 674ILE A 697THR A 699MET A 702GLY A 705LEU A 753 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNonePTR A 701 ( 3.5A)NoneNone | 0.60A | 6fnmA-2qobA:30.9 | 6fnmA-2qobA:69.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6FNM_A_1N1A1001_1 (-) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 8 / 12 | VAL A 635ALA A 651LYS A 653GLU A 670MET A 702GLY A 705LEU A 753SER A 763 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNonePTR A 701 ( 3.5A)NoneNoneNone | 0.77A | 6fnmA-2qobA:30.9 | 6fnmA-2qobA:69.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_G_ZOLG401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) | 4 / 7 | ASP A 166ARG A 10GLN A 304LYS A 300 | BME A 403 (-4.3A)NoneNoneNone | 1.38A | 6g31G-3fnbA:2.3 | 6g31G-3fnbA:13.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD4_A_STIA604_0 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670MET A 674ILE A 697THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 1.04A | 6hd4A-2qobA:26.1 | 6hd4A-2qobA:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD4_B_STIB602_0 (TYROSINE-PROTEINKINASE ABL1) |
2qob | EPHRIN RECEPTOR (Homosapiens) | 7 / 12 | VAL A 635ALA A 651GLU A 670MET A 674ILE A 697THR A 699ASP A 764 | BME A 1 (-4.9A)PTR A 701 ( 4.7A)NoneNoneNoneNoneNone | 1.02A | 6hd4B-2qobA:26.2 | 6hd4B-2qobA:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
1qdn | PROTEIN(N-ETHYLMALEIMIDESENSITIVE FUSIONPROTEIN (NSF)) (Cricetulusgriseus) | 5 / 11 | PHE A 125ASN A 180LEU A 176GLY A 175PHE A 130 | NoneNoneBME A 401 (-4.1A)NoneNone | 1.18A | 6r2eG-1qdnA:0.0 | 6r2eG-1qdnA:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 7DFR_A_FOLA161_1 (DIHYDROFOLATEREDUCTASE) |
3oga | NUCLEOSIDETRIPHOSPHATASE NUDI (Salmonellaenterica) | 3 / 3 | ASP A 97LEU A 10ARG A 73 | NoneNoneBME A 142 ( 3.9A) | 0.74A | 7dfrA-3ogaA:undetectable | 7dfrA-3ogaA:20.44 |